Oxidative stress level and tyrosinase activity in vitiligo patients

Indian Journal of Dermatology

Volumn 55, Issue 1, 2010, Pages 15-19

  Eskandani, M ^a   Golchai, J ^b   Pirooznia, N ^a   Hasannia, S ^a  

^a UNIVERSITY OF GUILAN   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Comet assay; Oxidative stress; Tyrosinase; Vitiligo

Indexed keywords

EUMELANIN; MONOPHENOL MONOOXYGENASE; NEUROTRANSMITTER;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DNA STRAND BREAKAGE; ENZYME ACTIVITY; FEMALE; HEREDITY; HUMAN; HUMAN TISSUE; MALE; MELANOGENESIS; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; VITILIGO;

EID: 77949543538     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.60344     Document Type: Article

References (21)

1. Ortonne JP, Bose SK. Vitiligo: Where do we stand? Pigment Cell Res 1993;8:61-72.
2. Lerner AB. Vitiligo. J Invest Dermatol 1959;32:285-310.
3. Le Poole IC, Das PK, van Den Wijngaard RM, Bose JD, Westerhof W. Review of the etiopathomechanism of vitiligo: A convergence theory. Exp Dermatol 1993;2:145-153
4. Njoo MD, Westerhof W. Vitiligo: Pathogenesis and treatment. Am J Clin Dermatol 2001;2:167-181
5. García-Borrón JC, Sánchez-Laorden BL, Jiménez-Cervantes C. Melanocortin-1 receptor structure and functional regulation. Pigment Cell Res 2005;18:393-410.
6. Abdel-Malek ZA, Scott MC, Furumura M, Lamoreux ML, Ollmann M, Barsh GS, et al. The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes. J Cell Sci 2001;114:1019-1024
7. Lei TC, Virador VM, Vieira WD, Hearing VJ. A melanocyte-keratinocyte coculture model to assess regulators of pigmentation in vitro. Analytical Biochem 2002;305:260-268
8. García-Molina F, Hiner AN, Fenoll LG, Rodríguez-Lopez JN, García-Ruiz PA, García-Cánovas F, et al. Mushroom tyrosinase: Catalase activity, inhibition, and suicide inactivation. J Agric Food Chem 2005;53:3702-3709
9. Giovannellia L, Bellandib S, Pitozzia V, Fabbrib P, Dolaraa PP, Morettib S. Increased oxidative DNA damage in mononuclear leukocytes in vitiligo. Mutat Res 2004;556:101-106
10. Spencer JD, Gibbons NC, Rokos H, Peters EM, Wood JM, Schallreuter KU. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo. J Investig Dermatol 2007;127:411-420
11. Schallreuter KU, Moore J, Wood JM, Beazley WD, Gaze DC. In vivo and in vitro evidence for hydrogen peroxide accumulation in the epidermis of patients of vitiligo and its successful removal by UVB activated pseudocatalase. J Invest Dermatol Symp Proc 2007;4:91-96
12. Dell'Anna ML, Maresca V, Brigandi S, Camrea E, Falchi M, Picardo M. Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 2001;4:908-913
13. Giovannelli L, Pitozzi V, Riolo S, Dolara P. Measurement of DNA breaks and oxidative damage in polymorphonuclear and mononuclear white blood cells: A novel approach using the Comet assay. Mutat Res 2003;538:71-80.
14. Cohen-Solal KA, Crespo-Carbone SM, Namkoong J, Mackason KR, Roberts KG, Reuhl KR, et al. Progressive appearance of pigmentation in amelanotic melanoma lesions. Pigment Cell Res 2002;15:282-289
15. Tripathi RK, Chaya Devi C, Ramaiah A. pH-dependent interconversion of two forms of tyrosinase in human skin. Biochem J 1998;252:481-487
16. Aberdam E, Bertolotto C, Sviderskaya EV, de Thillot V, Hemesath TJ, Fisher DE, et al. Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. Biol Chem 1998;273: 19560-19565
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-252
18. Winder AJ, Harris H. New assays for tyrosine hydroxylase and dopa oxidase activities of tyrosinase. Eur J Biochem 1991;198:317-326
19. Maresca V, Roccella M, Roccella F, Camera E, Del Porto G, Passi S, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997;109:1081-1085
20. Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991;97:1081-1085
21. Dell'Anna ML, Maresca V, Briganti S, Camera E, Falchi M, Picardo M. Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 2001;117:908-913